No Data
No Data
R1 RCM Surges After TCP-ASC Says It's in the Process of Finalizing Deal Proposal
Analysts Offer Insights on Healthcare Companies: R1 RCM (RCM), Legend Biotech (LEGN) and Intuitive Surgical (ISRG)
Buy Rating on R1 RCM Amid Acquisition Interest and Market Undervaluation
A Quick Look at Today's Ratings for R1 RCM(RCM.US), With a Forecast Between $14 to $20
On Jul 03, major Wall Street analysts update their ratings for $R1 RCM(RCM.US)$, with price targets ranging from $14 to $20.Morgan Stanley analyst Craig Hettenbach maintains with a buy rating, and mai
New Mountain Capital Proposes Buyout of R1 RCM
By Colin Kellaher Private-equity firm New Mountain Capital has submitted a bid to buy R1 RCM in a deal that values the revenue-cycle-management provider at around $5.58 billion. New Mountain, which
Buy Rating Affirmed for R1 RCM on Market Leadership and AI Growth Prospects